Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial

The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms.

Saved in:
Bibliographic Details
Main Authors: Meixner, Eva (Author) , Wark, Antje (Author) , Forster, Tobias (Author) , Weykamp, Fabian (Author) , Uzun-Lang, Kristin (Author) , König, Laila (Author) , Lindel, Katja (Author) , Oelmann-Avendano, Jan Tobias (Author) , Krisam, Johannes (Author) , Schneeweiss, Andreas (Author) , Ellerbrock, Malte (Author) , Mielke, Thomas (Author) , Hörner-Rieber, Juliane (Author) , Herfarth, Klaus (Author) , Debus, Jürgen (Author) , Arians, Nathalie (Author)
Format: Article (Journal)
Language:English
Published: 09 January 2023
In: Radiation oncology
Year: 2023, Volume: 18, Pages: 1-14
ISSN:1748-717X
DOI:10.1186/s13014-023-02198-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-023-02198-4
Get full text
Author Notes:Eva Meixner, Antje Wark, Tobias Forster, Fabian Weykamp, Kristin Lang, Laila König, Katja Lindel, Jan Tobias Oelmann-Avendano, Johannes Krisam, Andreas Schneeweiss, Malte Ellerbrock, Thomas Mielke, Juliane Hörner-Rieber, Klaus Herfarth, Jürgen Debus and Nathalie Arians
Description
Summary:The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms.
Item Description:Gesehen am 21.11.2023
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-023-02198-4